journal article·2012-04-19Open access

Bone Substitute Effect on Vascularization and Bone Remodeling after Application of phVEGF165 Transfected BMSC

Florian Geiger, Mirjam Beverungen, Helga Lorenz, Julia Wieland, Michael Fehr, Philip Kasten

Abstract

VEGF (vascular endothelial growth factor) promotes vascularization and remodeling of bone substitutes. The aim of this study was to examine the effect of distinct resorbable ceramic carriers on bone forming capacities of VEGF transfected bone marrow stromal cells (BMSC). A critical size defect of the radius in rabbits was filled either by a low surface scaffold called beta-TCP (tricalciumphsphate) or the high surface scaffold CDHA (calcium deficient hydroxy-apatite) loaded with autologous BMSC, which were either transfected with a control plasmid or a plasmid coding for phVEGF165. They were compared to unloaded scaffolds. Thus, six treatment groups (n = 6 in each group) were followed by X-ray over 16 weeks. After probe retrieval, the volume of new bone was measured by micro-CT scans and vascularization was assessed in histology. While only minor bone formation was found in both carriers when implanted alone, BMSC led to increased osteogenesis in both carriers. VEGF promoted vascularization of the scaffolds significantly in contrast to BMSC alone. Bone formation was increased in the beta-TCP group, whereas it was inhibited in the CDHA group that showed faster scaffold degradation. The results indicate that the interaction of VEGF transfected BMSC with resorbable ceramic carrier influences the ability to promote bone healing.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Periodontal Regeneration and Treatments · Dental Implant Techniques and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Experimental Orthopedics, Orthopedic University Hospital of Heidelberg, Heidelberg 69118, Germany

Department of Spine Surgery, Orthopedic University Hospital Friedrichsheim, J.W. Goethe University of Frankfurt, Frankfurt, Main 60528, Germany

University of Veterinary Medicine Hannover, Hannover 30559, Germany

Harlan Cytotest Cell Research GmbH, Rossdorf 64380, Germany

Department of Orthopedic Surgery, University of Dresden, Dresden 01307, Germany

References (31)

Show source-provided references
1. Angiogenesis in fracture repair10.1097/00003086-199810001-00010 ↗
2. Composite implant of native bovine bone morphogenetic protein (BMP) and biocoral in the treatment of scaphoid nonunions—A preliminary study10.1177/145749690209100210 ↗
3. Periodontal repair in dogs: Guided tissue regeneration enhances bone formation in sites implanted with a coral-derived calcium carbonate biomaterial10.1111/j.1600-051X.2004.00632.x ↗
4. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation10.1038/9467 ↗
5. Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigs10.1046/j.1365-201X.2002.01018.x ↗
6. Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats10.1016/S8756-3282(03)00053-X ↗
7. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis10.1359/JBMR.050708 ↗
8. Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo10.1096/fj.02-0514fje ↗
9. Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues10.1002/jgm.392 ↗
10. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects10.1359/JBMR.050701 ↗
11. VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute10.1016/j.bone.2007.06.018 ↗
12. The effect of platelet-rich plasma on healing in critical-size long-bone defects10.1016/j.biomaterials.2008.06.014 ↗
13. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier10.1016/j.biomaterials.2005.03.001 ↗
14. Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, beta-tricalcium phosphate and demineralized bone matrix10.1016/S0142-9612(03)00062-0 ↗
15. Coral grafting supplemented with bone marrow10.1302/0301-620X.81B4.0810719 ↗
16. Calcium orthophosphates in medicine: From ceramics to calcium phosphate cements10.1016/S0020-1383(00)80022-4 ↗
17. Properties of osteoconductive biomaterials: Calcium phosphates10.1097/00003086-200202000-00009 ↗
18. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells10.1182/blood.V98.9.2615 ↗
19. Osteogenetic properties of reimplanted decalcified and undecalcified autologous bone in the rabbit radius
20. Immunohistochemistry of matrix markers in Technovit 9100 New-embedded undecalcified bone sections10.22203/eCM.v006a06 ↗
21. Comparative performance of three ceramic bone graft substitutes10.1016/j.spinee.2006.07.017 ↗
22. Engineering principles of clinical cell-based tissue engineering10.2106/00004623-200407000-00029 ↗
23. Healing of an ulnar defect using a proprietary TCP bone graft substitute, JAX, in association with autologous osteogenic cells and growth factors10.1016/j.bone.2006.11.004 ↗
24. New technologies for the enhancement of skeletal repair10.1016/j.injury.2007.02.010 ↗
25. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover10.1073/pnas.152324099 ↗
26. Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes10.1002/1097-4636(200101)54:1<129::AID-JBM16>3.0.CO;2-D ↗
27. Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-210.1016/S0142-9612(00)00322-7 ↗
28. rhVEGF 165 delivered in a porous beta-tricalcium phosphate scaffold accelerates bridging of critical-sized defects in rabbit radii10.1002/jbm.a.32403 ↗
29. Preclinical and clinical experience in vascular gene therapy: Advantages over conservative/standard therapy
30. Composite implant of native bovine bone morphogenetic protein (BMP), collagen carrier and biocoral in the treatment of resistant ulnar nonunions: Report of five preliminary cases10.1007/s00402-003-0599-4 ↗
31. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2)10.1097/01.bsd.0000211231.83716.4b ↗